Clene Inc. (CLNN) Key Metrics
CLNN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $44.1M
- Enterprise value
- $73.7M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 223.7 10-yr median 137.9
- Price / book
- 7.8 10-yr median 20.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.92
CLNN key metrics, 2017–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCLNN valuation Price multiples at each fiscal year-end price.
Price / sales+168.0%
289.4
2025 · hover or tap a bar for each year
20172025
Free cash flow yield+25.7 pts
−32.1%
2025 · hover or tap a bar for each year
20172025
CLNN returns How much profit the business earns on the capital it uses.
Return on assets−16.2 pts
−115.1%
2025 · hover or tap a bar for each year
20172025
Asset turnover+2.5%
0.01
2025 · hover or tap a bar for each year
20172025
CLNN per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−58.8%
$0.02
2025 · hover or tap a bar for each year
20172025
Earnings per share
−$2.65
2025 · hover or tap a bar for each year
20172025
Free cash flow per share
−$1.89
2025 · hover or tap a bar for each year
20172025
Book value per share
−$1.78
2025 · hover or tap a bar for each year
20172025
Shares outstanding+41.8%
9.9M
2025 · hover or tap a bar for each year
20172025
CLNN financial health Debt, liquidity and how easily interest is covered.
Net debt+$7.8M
$16.5M
2025 · hover or tap a bar for each year
20172025
Current ratio−46.9%
0.83
2025 · hover or tap a bar for each year
20172025
Interest coverage
-8.6
2025 · hover or tap a bar for each year
20172025
Debt / assets+56.8%
1.20
2025 · hover or tap a bar for each year
20172025
CLNN efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−27 days
895 days
2025 · hover or tap a bar for each year
20172025
Days of inventory+172 days
446 days
2025 · hover or tap a bar for each year
20172025
Days payables outstanding+1,895 days
9,049 days
2025 · hover or tap a bar for each year
20172025
Cash conversion cycle−1,750 days
-7,708 days
2025 · hover or tap a bar for each year
20172025
Capex / revenue+15.1 pts
19.5%
2025 · hover or tap a bar for each year
20172025
CLNN valuation history
Fiscal year-endToday9-year median
CLNN returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CLNN debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CLNN price vs earnings per share
Share price at year-endEPS (right axis)
CLNN key metrics
2017–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||
| Market capitalization | $57.9M | $36.9M | $31.1M | $65.2M | $252.4M | $630.8M | $727.9M | $617.8M | — |
| Enterprise value | $74.4M | $45.6M | $28.3M | $73.7M | $226.1M | $575.9M | $722.0M | $620.3M | — |
| Price / sales | 289.4 | 108.0 | 47.6 | 137.9 | 349.1 | — | — | — | — |
| Price / book | — | — | 2.3 | 20.1 | 20.0 | — | 149.0 | 123.6 | — |
| EV / sales | 371.8 | 133.4 | 43.3 | 155.8 | 312.8 | — | — | — | — |
| Earnings yield | −45.2% | −106.7% | −159.0% | −45.9% | −3.9% | −3.1% | −2.2% | −0.0% | — |
| Free cash flow yield | −32.1% | −57.8% | −98.0% | −67.8% | −14.2% | −3.1% | −1.9% | −0.2% | — |
| Shareholder yield (dividends + buybacks) | — | — | — | 0.0% | 0.0% | 0.0% | — | — | — |
| Share price at fiscal year-end | $5.87 | $5.31 | $5.93 | $20.00 | $82.00 | $180.20 | $209.69 | $198.00 | — |
| Per share | |||||||||
| Revenue per share | $0.02 | $0.05 | $0.12 | $0.15 | $0.23 | $0.06 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$2.65 | −$5.67 | −$9.43 | −$9.18 | −$3.16 | −$5.51 | −$4.65 | −$0.09 | −$0.00 |
| Operating cash flow per share | −$1.88 | −$3.07 | −$5.75 | −$11.97 | −$11.25 | −$5.41 | −$3.80 | −$0.07 | — |
| Free cash flow per share | −$1.89 | −$3.07 | −$5.81 | −$13.55 | −$11.68 | −$5.52 | −$3.89 | −$0.31 | — |
| Cash per share | $0.53 | $1.75 | $6.67 | $7.15 | $16.34 | $16.93 | $2.53 | $0.24 | — |
| Book value per share | −$1.78 | −$1.27 | $2.55 | $0.99 | $4.09 | $0.10 | $1.41 | $1.60 | — |
| Tangible book value per share | −$1.78 | −$1.27 | $2.55 | $0.99 | $4.09 | $0.10 | $1.41 | $1.60 | — |
| Capex per share | $0.00 | $0.00 | $0.06 | $1.59 | $0.43 | $0.11 | $0.08 | $0.24 | — |
| Debt per share | $2.20 | $3.00 | $6.13 | $9.76 | $7.81 | $1.23 | $0.83 | $1.03 | — |
| Shares outstanding | 9.9M | 7.0M | 5.2M | 3.3M | 3.1M | 3.5M | 3.5M | 3.1M | 3.1M |
| Change in shares outstanding | +41.8% | +32.5% | +60.9% | +5.9% | −12.1% | +0.8% | +11.3% | 0.0% | — |
| Returns & profitability | |||||||||
| Return on equity (ROE) | — | — | −595.5% | −377.9% | −150.6% | −737.5% | −326.8% | −5.5% | — |
| Return on invested capital (ROIC) | — | — | −287.3% | — | — | — | — | −4.3% | — |
| Return on assets (ROA) | −115.1% | −98.9% | −102.2% | −55.6% | −14.8% | −46.4% | −52.1% | −0.6% | — |
| Return on tangible assets | −144.4% | −144.1% | −94.6% | −67.2% | −15.4% | −28.2% | −108.6% | −0.6% | — |
| Financial health | |||||||||
| Total debt | $21.7M | $20.8M | $32.2M | $31.8M | $24.0M | $4.3M | $2.9M | $3.2M | — |
| Cash & short-term investments | $5.2M | $12.2M | $35.0M | $23.3M | $50.3M | $59.3M | $8.8M | $743,783 | — |
| Net debt | $16.5M | $8.7M | −$2.8M | $8.5M | −$26.2M | −$55.0M | −$5.9M | $2.5M | — |
| Debt / equity | — | — | 2.40 | 9.83 | 1.91 | 12.68 | 0.59 | 0.64 | — |
| Debt / assets | 1.20 | 0.76 | 0.61 | 0.72 | 0.38 | 0.06 | 0.19 | 0.07 | — |
| Current ratio | 0.83 | 1.57 | 1.53 | 2.11 | 9.06 | 5.40 | 2.20 | 3.56 | — |
| Quick ratio | 0.83 | 1.56 | 1.53 | 2.10 | 9.05 | 5.38 | 2.19 | 3.56 | — |
| Interest coverage | -8.6 | -8.1 | -8.9 | -14.7 | -57.4 | -21.3 | -185.6 | — | — |
| Working capital | −$1.8M | $5.9M | $13.5M | $15.3M | $48.6M | $51.3M | $5.2M | $568,236 | — |
| Invested capital | −$1.1M | −$169,000 | $10.6M | $11.7M | −$13.6M | −$54.6M | −$1.0M | $7.5M | — |
| Tangible asset value | −$17.6M | −$8.9M | $13.4M | $3.2M | $12.6M | $341,000 | $4.9M | $5.0M | — |
| Net current asset value | −$26.7M | −$20.0M | −$99,000 | −$12.1M | $4.1M | −$4.9M | −$513,000 | −$41.4M | — |
| Graham net-net per share | −$3.05 | −$3.41 | −$0.56 | −$4.81 | $0.34 | −$1.97 | −$0.21 | −$13.27 | — |
| Capital allocation | |||||||||
| Share buybacks (net) | — | — | — | $0 | $0 | $0 | — | — | — |
| Capex / revenue | 19.5% | 4.4% | 50.5% | 1,094.9% | 184.2% | 187.9% | — | — | — |
| Capex / depreciation | 0.03 | 0.01 | 0.19 | 5.08 | 1.39 | 0.40 | 0.35 | 1.12 | — |
| Stock-based compensation / revenue | 3,191.0% | 2,325.4% | 1,394.0% | 1,799.8% | 1,712.9% | 369.4% | — | — | — |
| R&D / revenue | 7,005.5% | 5,864.9% | 4,075.7% | 6,748.4% | 3,930.3% | 7,380.6% | — | — | — |
| SG&A / revenue | 4,614.5% | 3,890.9% | 2,204.6% | 3,417.1% | 2,602.1% | 1,583.5% | — | — | — |
| Efficiency | |||||||||
| Days sales outstanding | 895.2 | 922.6 | 1,201.0 | 1,766.7 | 954.7 | 2,456.7 | — | — | — |
| Days of inventory on hand | 445.6 | 273.8 | 120.7 | 589.6 | 146.5 | 614.9 | 11.4 | — | — |
| Days payables outstanding | 9,048.6 | 7,154.0 | 6,814.3 | 34,653.9 | 1,924.1 | 5,651.9 | 402.5 | — | — |
| Cash conversion cycle (days) | -7,707.8 | -5,957.6 | -5,492.6 | -32,297.6 | -823.0 | -2,580.3 | — | — | — |
| Receivables turnover | 0.41 | 0.40 | 0.30 | 0.21 | 0.38 | 0.15 | 0.00 | — | — |
| Payables turnover | 0.04 | 0.05 | 0.05 | 0.01 | 0.19 | 0.06 | 0.91 | — | — |
| Inventory turnover | 0.82 | 1.33 | 3.02 | 0.62 | 2.49 | 0.59 | 32.14 | — | — |
| Asset turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | — |
| Average receivables | $490,500 | $864,500 | $2.2M | $2.3M | $1.9M | $1.4M | $604,000 | — | — |
| Average payables | $1.1M | $1.4M | $2.3M | $2.5M | $1.5M | $1.0M | $992,500 | $1.1M | — |
| Average inventory | $52,500 | $52,500 | $40,000 | $42,000 | $116,000 | $109,500 | $28,000 | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Computed from CLNN's annual financial statements (latest annual report filed March 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CLNN valuation and financial ratios
It ended the year with $21.7 million of debt and $5.2 million in cash and short-term investments, net debt of $16.5 million. The share count rose 216.0% from 3.1M to 9.9M over 8 years.
See the CLNN income statement, the CLNN chart for price history, or the CLNN stock overview for the latest quote and news.
CLNN key metrics FAQ
How much debt does Clene have?
Clene had total debt of $21.7 million at the end of fiscal 2025.
What is Clene's free cash flow yield?
Clene generated -$18.6 million of free cash flow in fiscal 2025, a free cash flow yield of −32.1% on its market value at year-end ($57.9 million).
What is Clene's current ratio?
Clene's current ratio was 0.83 at the end of fiscal 2025: current assets were 0.83 times current liabilities.